Denmark -
Denmark -
Lægemiddelstyrelsen (Danish Medicines Agency)
synerpril 20+6 mg tabletter
n.v. organon - enalaprilmaleat, hydrochlorthiazid - tabletter - 20+6 mg
Denmark -
Denmark -
Lægemiddelstyrelsen (Danish Medicines Agency)
corodil comp 20+12,5 mg tabletter
hexal a/s - enalaprilmaleat, hydrochlorthiazid - tabletter - 20+12,5 mg
Denmark -
Denmark -
Lægemiddelstyrelsen (Danish Medicines Agency)
enahexal comp 20 mg/6 mg 20+6 mg tabletter
hexal ag - enalaprilmaleat, hydrochlorthiazid - tabletter - 20+6 mg
Denmark -
Denmark -
Lægemiddelstyrelsen (Danish Medicines Agency)
enahyton 20 mg/6 mg 20+6 mg tabletter
hexal ag - enalaprilmaleat, hydrochlorthiazid - tabletter - 20+6 mg
Denmark -
Denmark -
Lægemiddelstyrelsen (Danish Medicines Agency)
lirpalane 20+12,5 mg tabletter
stada arzneimittel ag - enalaprilmaleat, hydrochlorthiazid - tabletter - 20+12,5 mg
Kesatuan Eropah -
Denmark -
EMA (European Medicines Agency)
bindren
mitsubishi pharma europe ltd - colestilan - hyperfosfatæmi - lægemidler til behandling af hyperkaliæmi og hyperphosphatæmi - behandling af hyperphosphatæmi hos voksne patienter med kronisk nyresygdom, fase 5, der modtager hæmodialyse eller peritonealdialyse.
Kesatuan Eropah -
Denmark -
EMA (European Medicines Agency)
entresto
novartis europharm limited - sacubitril, valsartan - hjertefejl - angiotensin ii antagonister, andre kombinationer, agenter handler på renin-angiotensin systemet - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
Kesatuan Eropah -
Denmark -
EMA (European Medicines Agency)
neparvis
novartis europharm limited - sacubitril, valsartan - hjertefejl - agenter, der virker på renin-angiotensinsystemet - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
Denmark -
Denmark -
Lægemiddelstyrelsen (Danish Medicines Agency)
diovan 160 mg filmovertrukne tabletter
novartis healthcare a/s - valsartan - filmovertrukne tabletter - 160 mg
Denmark -
Denmark -
Lægemiddelstyrelsen (Danish Medicines Agency)
diovan 160 mg filmovertrukne tabletter
paranova danmark a/s - valsartan - filmovertrukne tabletter - 160 mg